Evidence map›Paper›PMID 32993025›Full record

ArticleInternational journal of molecular sciences2020

Pressure Stimuli Improve the Proliferation of Wharton's Jelly-Derived Mesenchymal Stem Cells under Hypoxic Culture Conditions.

Sang Eon Park, Hyeongseop Kim, Soojin Kwon, Suk-Joo Choi, Soo-Young Oh, Gyu Ha Ryu, Hong Bae Jeon, Jong Wook Chang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Mechanobiology in Cells and Tissues.International journal of molecular sciences · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sang Eon ParkStem Cell Institute, ENCell Co. Ltd., Seoul 06072, Korea.ORCID 0000-0003-3315-6426
Hyeongseop KimStem Cell Institute, ENCell Co. Ltd., Seoul 06072, Korea.ORCID 0000-0001-8546-6472
Soojin KwonStem Cell Institute, ENCell Co. Ltd., Seoul 06072, Korea.
Suk-Joo ChoiDepartment of Obstetrics and Gynecology, Samsung Medical Center, Seoul 06351, Korea.
Soo-Young OhDepartment of Obstetrics and Gynecology, Samsung Medical Center, Seoul 06351, Korea.
Gyu Ha RyuDepartment of Medical Device Management and Research, SAIHST, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Hong Bae JeonStem Cell Institute, ENCell Co. Ltd., Seoul 06072, Korea.
Jong Wook ChangStem Cell Institute, ENCell Co. Ltd., Seoul 06072, Korea.
Samsung Medical Center · KRCell Biotech (South Korea) · KR

Funding

Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) HI14C3484National Research Foundation of Korea grants 2017R1D1A1B03028083National Research Foundation of Korea grants 2017R1D1A1B03033239National Research Foundation of Korea grants 2018R1D1A1B07046902Technology Development Program funded by the Ministry of SMEs and Startups (MSS, Korea) S2644635
6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) are safe, and they have good therapeutic efficacy through their paracrine action. However, long-term culture to produce sufficient MSCs for clinical use can result in side-effects, such as an inevitable senescence and the reduction of the therapeutic efficacy of the MSCs. In order to overcome this, the primary culture conditions of the MSCs can be modified to simulate the stem cells' niche environment, resulting in accelerated proliferation, the achievement of the target production yield at earlier passages, and the improvement of the therapeutic efficacy. We exposed Wharton's jelly-derived MSCs (WJ-MSCs) to pressure stimuli during the primary culture step. In order to evaluate the proliferation, stemness, and therapeutic efficacy of WJ-MSCs, image, genetic, and Western blot analyses were carried out. Compared with standard incubation culture conditions, the cell proliferation was significantly improved when the WJ-MSCs were exposed to pressure stimuli. However, the therapeutic efficacy (the promotion of cell proliferation and anti-apoptotic effects) and the stemness of the WJ-MSCs was maintained, regardless of the culture conditions. Exposure to pressure stimuli is a simple and efficient way to improve WJ-MSC proliferation without causing changes in stemness and therapeutic efficacy. In this way, clinical-grade WJ-MSCs can be produced rapidly and used for therapeutic applications.

Indexed as

Cell DifferentiationCell ProliferationParacrine CommunicationStress, MechanicalCells, CulturedHumansMesenchymal Stem Cellshypoxiaphysical forcepressureproliferationWharton’s jelly-derived mesenchymal stem cells

Identifiers

PMID32993025
PMCPMC7583852
OpenAlexW3088234713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.